What is Alumis Inc.'s long-term investments?

Alumis Inc. (ALMS) reported long-term investments of $46.6M in Q1 2026.

What does long-term investments mean?

Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.

TG TherapeuticsTGTX

$72.22M-49.9%

Revenue$1.7M-90.0%

Operating income-$98.4M+3.1%

Net income-$93.1M+6.0%

EPS (diluted)-$0.74+59.3%

Cash & equivalents$63.9M-50.3%

Total debt$35.7M+1,881%

Total equity$567.0M+237%

Total assets$671.6M+157%

Operating cash flow-$87.1M-8.4%

CapEx$164.0K+343%

Free cash flow-$87.2M-8.5%

Market cap$3.17B+739%

Operating margin-5,364%—

Net margin-2,825.7%—

FCF margin-4,487.4%—

Return on equity-64.6%—

Debt / equity0.1×+0.1×

Current ratio7.5×+3.8×

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Alumis Inc.'s long-term investments?: Alumis Inc. (ALMS) reported long-term investments of $46.6M in Q1 2026.
What does long-term investments mean?: Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.